Palivizumab

Therapeutic Palivizumab antibody from the original Synagis® commercial drug
  • Therapeutic drugs as aliquots
  • Multiple drug batches
  • Consumable, so no license needed
  • Prompt Delivery
  • Fraction of the original drug price

BATCH NUMBER: 382291

Amount per aliquot: 4 mg

In stock

Product Specifications:​​

  • Quality Standard clinical-grade
  • Product Concentration 100 mg/mL
  • Volume per Aliquot 40 µL
  • Quantity per Aliquot 4 mg
  • Origin of the Commercial Drug DE
  • Batch Number 382291
  • Storage Temperature -70°C
  • Original Therapeutic Expiry Date 2019.04

Our products are for research use only. The “therapeutic expiration date” refers to the expiry date for patient adminstration and is not applicable to the shelf life of the aliquot. Aliquot storage at -70°C ensures fully functional molecules even after the mentioned expiry date.

Product Information:

“Evidentic offers repackaged finished pharmaceutical products (e.g RMP/RLD). We refer to the repackaged RMP/RLD products synonymously as drug aliquots, aRMP, or aliquots.

We offer batches of original drug aliquots in low-binding Eppendorf tubes for research use only. We provide license-free drug aliquots with long, short or even “negative shelf life” by storing the products at the recommended temperature -70°C, ensuring fully functional molecules for research purposes.”

As ‘raw material’ for the production of drug aliquots, Evidentic sources RMP from the European (EU) market. As a licensed pharmaceutical wholesaler, Evidentic is committed to Good Distribution Practice (GDP) compliance with respect to the procurement, storage and shipment of RMP.

Drug aliquots are manufactured by repackaging RMP in a qualified laboratory. The aliquotation process is performed under a quality and manufacturing agreement between Evidentic and the contract manufacturer. Repackaging of RMP includes the following steps: opening the secondary and primary RMP containers and transferring the specified volumes of RMP into an Eppendorf 0.5 ml low-binding (or similar) tube. If the RMP is a lyophilized powder and not a highly concentrated solution, reconstitute the RMP according to the original manufacturer’s instructions and then aliquot as a highly concentrated solution.

For identification purposes, drug aliquots are labeled with the date of aliquoting, the original lot number of the RMP, the original expiration date of the RMP, the name of the active ingredient (INN), and a unique identification code.

Immediately after aliquoting, drug aliquots are stored at either 2-8 °C or -86 °C for long-term storage. All drug aliquots stored at 2-8 °C are transferred to -86 °C at least two weeks before the expiration date of the original RLD/RMP is reached.

Further quality or functional testing are not performed on the drug aliquots.

Target

Class of Molecule

Isotype

Host cells

Mouse myeloma cells

Prepared from (Reference drug)​

Synagis®

Therapeutic Area

Therapeutic Indications

Mechanism of Action (MoA)

Palivizumab is a humanised IgG1κ monoclonal antibody directed to an epitope in the A antigenic site of the fusion protein of respiratory syncytial virus (RSV).

Pharmacotherapeutic group​​

Immune sera and immunoglobulins

List of Excipients​

Histidine
Glycine

Ready to simplify your sourcing?

Here’s how to get started:

Select Your Licensed Molecules

Browse our shop and choose the licensed molecules you need. Don’t worry if you can’t find the molecule you’re looking for – we can source it for you!

Get a Quote

Receive a confidential, non-binding quote for the molecule(s) you choose.

Get Qualified & We Deliver

Complete our quick qualification process, place your order, and we’ll ship your molecule(s) within days.

Explore our Shop

More Reference Drugs as Aliquots

Filters Sort results
Reset Apply
Product Batch
Expiry Date
Brand & Origin
Amount per Aliquot
Select Quantity
Discount
Price per Aliquot
Adalimumab 1120078A
2021.12
Amgevita®
DE
2 mg
Max: 10
Min: 1
Step: 1
aliquot
Order on demand:
0%
304,00 € /aliquot
Add to Wishlist
Adalimumab 1251992
2026.02
Humira®
DE
4 mg
Max: 20
Min: 1
Step: 1
aliquot
338,00 €/mg
Add to Wishlist
Adalimumab 1825216
2023.02
Hulio®
DE
2 mg
Max: 10
Min: 1
Step: 1
aliquot
Order on demand:
0%
304,00 € /aliquot
Add to Wishlist
Adalimumab 1909689A
2023.10
Hukyndra®
DE
2 mg
Max: 10
Min: 1
Step: 1
aliquot
Order on demand:
0%
354,00 € /aliquot
Add to Wishlist
Adalimumab 2LJP01T11
2024.02
Yuflyma®
DE
4 mg
Max: 3
Min: 1
Step: 1
aliquot
Order on demand:
0%
354,00 € /aliquot
Add to Wishlist
Adalimumab 73254XH03
2018.12
Humira®
LV
4 mg
Max: 10
Min: 1
Step: 1
aliquot
Order on demand:
0%
451,00 € /aliquot
Add to Wishlist
Adalimumab 76287XH07
2019.03
Humira®
DE
4 mg
Max: 9
Min: 1
Step: 1
aliquot
Order on demand:
0%
451,00 € /aliquot
Add to Wishlist
Adalimumab 76287XH11
2019.03
Humira®
DE
4 mg
Max: 5
Min: 1
Step: 1
aliquot
Order on demand:
0%
451,00 € /aliquot
Add to Wishlist
Adalimumab 80315XH04
2019.07
Humira®
DE
4 mg
Max: 6
Min: 1
Step: 1
aliquot
Order on demand:
0%
451,00 € /aliquot
Add to Wishlist
Adalimumab AU034994
2023.10
Idacio®
DE
2 mg
Max: 10
Min: 1
Step: 1
aliquot
Order on demand:
0%
355,00 € /aliquot
Add to Wishlist
Adalimumab GR226512
2023.10
Imraldi®
DE
2 mg
Max: 10
Min: 1
Step: 1
aliquot
Order on demand:
0%
304,00 € /aliquot
Add to Wishlist
Adalimumab MA8208
2024.06
Hyrimoz®
DE
2 mg
Max: 10
Min: 1
Step: 1
aliquot
Order on demand:
0%
304,00 € /aliquot
Add to Wishlist